T. I. Kopaliani
T. I. Kopaliani has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Albert Akhobekov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
4 shared publications - Pervin A. Zeynalova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Clinical Hospital "Lapino" of the "Mother and Child" Group of Companies
3 shared publications - Zurab Merabovich Cheishvili
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
3 shared publications - A. M. Grigoryan
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
2 shared publications - Ali M. Mudunov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
2 shared publications - B. G. Pkheshkhova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
2 shared publications
Latest Publications
- Open Access
- 5 March 2025
- Published by Publishing House ABV Press in MD-Onco
- Vol. 5 (1) , 59-65
Multidisciplinary approach in management of patients with immune thrombocytopenia and ischemic heart disease
Immune thrombocytopenia in patients with concomitant cardiovascular disorders requiring antiplatelet and anticoagulant therapy can increase the risk of hemorrhages and arterial and venous thromboembolic complications. This situation necessitates special patient management. Multidisciplinary approach is important for patients requiring myocardial revascularization due to the necessity of administration of double or triple antiplatelet therapy.The article presents our experience in management of patients with immune thrombocytopenia and high functional class stable angina requiring coronary artery stent.
- 5 March 2025
- Published by Publishing House ABV Press in MD-Onco
- Vol. 5 (1) , 59-65
Open AccessMultidisciplinary approach in management of patients with immune thrombocytopenia and ischemic heart disease
Immune thrombocytopenia in patients with concomitant cardiovascular disorders requiring antiplatelet and anticoagulant therapy can increase the risk of hemorrhages and arterial and venous thromboembolic complications. This situation necessitates special patient management. Multidisciplinary approach is important for patients requiring myocardial revascularization due to the necessity of administration of double or triple antiplatelet therapy.The article presents our experience in management of patients with immune thrombocytopenia and high functional class stable angina requiring coronary artery stent.
- Open Access
- 20 September 2023
- Published by Publishing House ABV Press in MD-Onco
- Vol. 3 (3) , 42-47
Clinical case of successful treatment of a patient with anaplastic thyroid cancer in combination with ischemic heart disease and critical multivessel coronary artery disease
The article presents a clinical case of a patient with locally advanced anaplastic thyroid cancer and concomitant cardiovascular pathology. Anaplastic thyroid cancer is a very rare and highly aggressive disease requiring long-term multistage treatment, often using cardiotoxic drugs. Combination of this pathology with ischemic heart disease affecting coronary arteries is a complex clinical problem requiring timely evaluation of cardiac risk at every stage. Treatment of this patient cohort is possible only by a multidisciplinary team of specialists.
- 20 September 2023
- Published by Publishing House ABV Press in MD-Onco
- Vol. 3 (3) , 42-47
Open AccessClinical case of successful treatment of a patient with anaplastic thyroid cancer in combination with ischemic heart disease and critical multivessel coronary artery disease
The article presents a clinical case of a patient with locally advanced anaplastic thyroid cancer and concomitant cardiovascular pathology. Anaplastic thyroid cancer is a very rare and highly aggressive disease requiring long-term multistage treatment, often using cardiotoxic drugs. Combination of this pathology with ischemic heart disease affecting coronary arteries is a complex clinical problem requiring timely evaluation of cardiac risk at every stage. Treatment of this patient cohort is possible only by a multidisciplinary team of specialists.
- Open Access
- 11 September 2023
- Published by Publishing House ABV Press in Oncohematology
- Vol. 18 (3) , 35-43
An integrated treatment approach in patient with metastatic colorectal cancer and concomitant late cardiovascular complications of chemoradiotherapy for Hodgkin’s lymphoma. Clinical case
The high efficacy of the currently used combined chemoradiotherapy for Hodgkin’s lymphoma not only significantly increased overall survival, but also made it possible for most patients to achieve the same quality of life as in a healthy population. at the same time, the problem of identifying late treatment complications, in particular cardiovascular the high efficacy of the currently used combined chemoradiotherapy for Hodgkin’s lymphoma not only significantly increased overall survival, but also made it possible for most patients to achieve the same quality of life as in a healthy population. at the same time, the problem of identifying late treatment complications, in particular cardiovascular diseases, remains an urgent problem, the timely diagnosis of which is an important task. the development of a second malignant neoplasm and the appointment of drug antitumor therapy with cardiotoxic agents necessitate a multidisciplinary approach. In the presented clinical observation, such tactics of patient management made it possible not only to timely identify late cardiovascular complications of Hodgkin’s lymphoma chemoradiotherapy, but also to conduct treatment for the second malignant disease with cardiotoxic agents with a positive antitumor effect.
- 11 September 2023
- Published by Publishing House ABV Press in Oncohematology
- Vol. 18 (3) , 35-43
Open AccessAn integrated treatment approach in patient with metastatic colorectal cancer and concomitant late cardiovascular complications of chemoradiotherapy for Hodgkin’s lymphoma. Clinical case
The high efficacy of the currently used combined chemoradiotherapy for Hodgkin’s lymphoma not only significantly increased overall survival, but also made it possible for most patients to achieve the same quality of life as in a healthy population. at the same time, the problem of identifying late treatment complications, in particular cardiovascular the high efficacy of the currently used combined chemoradiotherapy for Hodgkin’s lymphoma not only significantly increased overall survival, but also made it possible for most patients to achieve the same quality of life as in a healthy population. at the same time, the problem of identifying late treatment complications, in particular cardiovascular diseases, remains an urgent problem, the timely diagnosis of which is an important task. the development of a second malignant neoplasm and the appointment of drug antitumor therapy with cardiotoxic agents necessitate a multidisciplinary approach. In the presented clinical observation, such tactics of patient management made it possible not only to timely identify late cardiovascular complications of Hodgkin’s lymphoma chemoradiotherapy, but also to conduct treatment for the second malignant disease with cardiotoxic agents with a positive antitumor effect.
- Open Access
- 22 May 2023
- Published by Publishing House ABV Press in MD-Onco
- Vol. 3 (2) , 35-39
Clinical case of surgical treatment of a patient with multivessel coronary artery disease and abdominal aortic aneurysm in combination with malignant tumor of the larynx
Combination of oncological and cardiological pathologies is a complex clinical problem requiring a multidisciplinary team of doctors for treatment of a patient. This article presents a case of successful treatment of a patient with serious concomitant pathologies.
- 22 May 2023
- Published by Publishing House ABV Press in MD-Onco
- Vol. 3 (2) , 35-39
Open AccessClinical case of surgical treatment of a patient with multivessel coronary artery disease and abdominal aortic aneurysm in combination with malignant tumor of the larynx
Combination of oncological and cardiological pathologies is a complex clinical problem requiring a multidisciplinary team of doctors for treatment of a patient. This article presents a case of successful treatment of a patient with serious concomitant pathologies.